LS Investment Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-15,887
Closed -$4.48M 734
2021
Q1
$4.48M Buy
15,887
+10,134
+176% +$2.86M 0.25% 107
2020
Q4
$1.63M Buy
5,753
+386
+7% +$109K 0.09% 198
2020
Q3
$1.48M Buy
5,367
+2,882
+116% +$792K 0.08% 202
2020
Q2
$565K Sell
2,485
-1,985
-44% -$451K 0.04% 338
2020
Q1
$681K Sell
4,470
-727
-14% -$111K 0.05% 285
2019
Q4
$781K Buy
5,197
+1,288
+33% +$194K 0.04% 354
2019
Q3
$554K Sell
3,909
-28
-0.7% -$3.97K 0.03% 422
2019
Q2
$493K Sell
3,937
-342
-8% -$42.8K 0.03% 463
2019
Q1
$472K Sell
4,279
-142
-3% -$15.7K 0.03% 480
2018
Q4
$433K Buy
4,421
+13
+0.3% +$1.27K 0.03% 462
2018
Q3
$544K Sell
4,408
-73
-2% -$9.01K 0.03% 463
2018
Q2
$445K Buy
4,481
+62
+1% +$6.16K 0.03% 545
2018
Q1
$390K Sell
4,419
-407
-8% -$35.9K 0.02% 589
2017
Q4
$476K Sell
4,826
-1,154
-19% -$114K 0.03% 516
2017
Q3
$576K Sell
5,980
-205
-3% -$19.7K 0.03% 453
2017
Q2
$585K Buy
6,185
+983
+19% +$93K 0.04% 430
2017
Q1
$425K Sell
5,202
-101
-2% -$8.25K 0.03% 529
2016
Q4
$450K Buy
5,303
+135
+3% +$11.5K 0.03% 446
2016
Q3
$385K Buy
5,168
+100
+2% +$7.45K 0.03% 474
2016
Q2
$385K Buy
5,068
+2,190
+76% +$166K 0.03% 517
2016
Q1
$200K Buy
2,878
+225
+8% +$15.6K 0.01% 638
2015
Q4
$160K Hold
2,653
0.01% 695
2015
Q3
$144K Sell
2,653
-74
-3% -$4.02K 0.01% 714
2015
Q2
$158K Buy
+2,727
New +$158K 0.01% 687